We are live on ! Find out more
LAB icon

Standard BioTools
LAB

131 hedge funds and large institutions have $854M invested in Standard BioTools in 2019 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 60 increasing their positions, 17 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

655% more call options, than puts

Call options by funds: $302K | Put options by funds: $40K

253% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 17

213% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 15

103% more capital invested

Capital invested by funds: $422M → $854M (+$433M)

32% more funds holding

Funds holding: 99 → 131 (+32)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

8.31% less ownership

Funds ownership: 101.5% → 93.19% (-8.3%)

Holders
131
Holders Change
+32
Holders Change %
+32.32%
% of All Funds
2.84%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
47
Increased
60
Reduced
17
Closed
15
Calls
$302K
Puts
$40K
Net Calls
+$262K
Net Calls Change
-$9K

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$19.2M
2
PHS
PFM Health Sciences
California
+$15.2M
3
RI
RTW Investments
New York
+$11M
4
Deutsche Bank
Deutsche Bank
Germany
+$10.8M
5
Renaissance Technologies
Renaissance Technologies
New York
+$9.64M

Top Sellers

1
LCS
Levin Capital Strategies
New York
-$98.9M
2
HVC
Healthcare Value Capital
New Jersey
-$3.88M
3
ICM
Indaba Capital Management
California
-$3.45M
4
PVI
Pura Vida Investments
New York
-$2.73M
5
Neuberger Berman Group
Neuberger Berman Group
New York
-$2.64M
Name Holding Trade Value Shares
Change 		Change in
Stake
IP
51
Intellectus Partners
California
$2.14M +$98.2K +9,316 +6%
EGI
52
EAM Global Investors
California
$2.12M – – –
SEI Investments
53
SEI Investments
Pennsylvania
$2.06M +$1.42M +134,532 +670%
PPA
54
Parametric Portfolio Associates
Washington
$1.9M +$1.22M +115,808 +422%
CCM
55
Cadence Capital Management
Massachusetts
$1.9M +$1.5M +142,562 New
CSS
56
Cubist Systematic Strategies
Connecticut
$1.87M +$1.21M +115,074 +443%
TCIM
57
TIAA CREF Investment Management
New York
$1.85M +$746K +70,793 +103%
JP Morgan Chase
58
JP Morgan Chase
New York
$1.67M -$1.49M -141,287 -53%
WMSA
59
Weiss Multi-Strategy Advisers
New York
$1.59M -$52.7K -5,000 -4%
Squarepoint
60
Squarepoint
New York
$1.59M +$488K +46,319 +63%
MSL
61
Mackay Shields LLC
New York
$1.55M +$1.23M +117,000 New
EGM
62
Engineers Gate Manager
New York
$1.48M +$598K +56,704 +104%
Connor, Clark & Lunn Investment Management (CC&L)
63
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.19M +$12.9K +1,224 +1%
Charles Schwab
64
Charles Schwab
California
$1.15M +$137K +12,966 +18%
AllianceBernstein
65
AllianceBernstein
Tennessee
$1.08M +$301K +28,557 +54%
ARTA
66
A.R.T. Advisors
New York
$1.01M +$804K +76,249 New
PP
67
PDT Partners
New York
$994K +$423K +40,150 +116%
New York State Common Retirement Fund
68
New York State Common Retirement Fund
New York
$981K +$174K +16,550 +29%
AR
69
Advisory Research
Illinois
$961K +$762K +72,334 New
FC
70
Fairpointe Capital
Illinois
$864K – – –
GCP
71
GSA Capital Partners
United Kingdom
$823K +$653K +61,910 New
California Public Employees Retirement System
72
California Public Employees Retirement System
California
$809K +$68.6K +6,506 +12%
BCM
73
Bridgeway Capital Management
Texas
$730K -$1.2M -113,627 -67%
CPC
74
Cookson Peirce & Co
Pennsylvania
$720K -$83.8K -7,950 -13%
California State Teachers Retirement System (CalSTRS)
75
California State Teachers Retirement System (CalSTRS)
California
$676K +$113K +10,707 +27%
1 2
3
4 5

LAB Hedge Fund Activity: Q1 2019 in Review

131 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q1 2019, worth a combined $854M — up 103% from $422M a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new LAB positions and 15 closed out — a net gain of 32 holders — while 60 added to existing stakes and 17 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $19.2M. The largest seller was Levin Capital Strategies, cutting an estimated $98.9M.

  • 131 institutional investors held Standard BioTools (LAB) as of Q1 2019, up from 99 in Q4 2018.
  • Funds reported $854M of Standard BioTools stock for Q1 2019, up 103% quarter-over-quarter.
  • 47 funds opened new Standard BioTools positions in Q1 2019 and 15 closed out, a net change of +32 holders.
  • The largest Standard BioTools buyer in Q1 2019 was Fidelity Investments, an estimated $19.2M added.
  • The largest Standard BioTools seller in Q1 2019 was Levin Capital Strategies, an estimated $98.9M sold.

Based on aggregated 13F filings for Q1 2019.